Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gavin Ha

Showing results (91-100 of 94) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 94 results.
Cancer Discovery|October 6, 2017
Genomic Heterogeneity as a Barrier to Precision Medicine in Gastroesophageal AdenocarcinomaEirini Pectasides, Matthew D Stachler, Sarah Derks, et al.
Nature|April 13, 2012
The clonal and mutational evolution spectrum of primary triple-negative breast cancersSohrab P Shah, Andrew Roth, Rodrigo Goya, et al.
Nature Communications|November 8, 2017
Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumorsViktor A Adalsteinsson, Gavin Ha, Samuel S Freeman, et al.
Nature Communications|October 8, 2025
Elucidating molecularly stratified single agent, and combination, therapeutic strategies targeting MCL1 for lethal prostate cancerJuan M Jiménez-Vacas, Daniel Westaby, Ines Figueiredo, et al.
Pageof 10

Showing results (91-100 of 94) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 94 results.
Cancer Discovery|October 6, 2017
Genomic Heterogeneity as a Barrier to Precision Medicine in Gastroesophageal AdenocarcinomaEirini Pectasides, Matthew D Stachler, Sarah Derks, et al.
Nature|April 13, 2012
The clonal and mutational evolution spectrum of primary triple-negative breast cancersSohrab P Shah, Andrew Roth, Rodrigo Goya, et al.
Nature Communications|November 8, 2017
Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumorsViktor A Adalsteinsson, Gavin Ha, Samuel S Freeman, et al.
Nature Communications|October 8, 2025
Elucidating molecularly stratified single agent, and combination, therapeutic strategies targeting MCL1 for lethal prostate cancerJuan M Jiménez-Vacas, Daniel Westaby, Ines Figueiredo, et al.
Pageof 10